The DOI matches its Crossref record; 466 of the 466 references it cites were found in a registry or an index.
Nanovehicular Intracellular Delivery Systems
Open accessAbstract
This article provides an overview of principles and barriers relevant to intracellular drug and gene transport, accumulation and retention (collectively called as drug delivery) by means of nanovehicles (NV). The aim is to deliver a cargo to a particular intracellular site, if possible, to exert a local action. Some of the principles discussed in this article apply to noncolloidal drugs that are not permeable to the plasma membrane or to the blood–brain barrier. NV are defined as a wide range of nanosized particles leading to colloidal objects which are capable of entering cells and tissues and delivering a cargo intracelullarly. Different localization and targeting means are discussed. Limited discussion on pharmacokinetics and pharmacodynamics is also presented. NVs are contrasted to micro-delivery and current nanotechnologies which are already in commercial use. Newer developments in NV technologies are outlined and future applications are stressed. We also briefly review the existing modeling tools and approaches to quantitatively describe the behavior of targeted NV within the vascular and tumor compartments, an area of particular importance. While we list “elementary” phenomena related to different level of complexity of delivery to cancer, we also stress importance of multi-scale modeling and bottom-up systems biology approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–466 of 466
Tieleman, D. P. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04461.x · Cited by 58
McLennan, D. N., Porter, C. J. H., Edwards, G. A., Martin, S. W., Heatherington, A. C., & Charman, S. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078790 · Cited by 57
Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways
Hua, F., Hautaniemi, S., Yokoo, R., & Lauffenburger, D. A. (2006) · Journal of The Royal Society Interface · doi:10.1098/rsif.2005.0109 · Cited by 56
Structural Identifiability of Physiologically Based Pharmacokinetic Models
Yates, J. W. T. (2006) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-006-9011-7 · Cited by 55
Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties
Ayhan, H., Tuncel, A., Bor, N. M., et al. (1996) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856295x00355 · Cited by 55
Furumoto, K., Nagayama, S., Ogawara, K., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.004 · Cited by 54
Erdoğan, S., Roby, A., & Torchilin, V. P. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060055t · Cited by 54
Mendoza, F. J., Espino, P. S., Cann, K. L., Bristow, N. A., McCrea, K., & Łoś, M. (2005) · PubMed · Cited by 53
Mortensen, M. W., Björkdahl, O., Sørensen, P. G., Hansen, T., Jensen, M., Gundersen, H. J. G., & Bjørnholm, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050206v · Cited by 53
Dasika, M. S., Burgard, A. P., & Maranas, C. D. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.069724 · Cited by 53
Adrian, J. E., Poelstra, K., Scherphof, G. L., Molema, G., Meijer, D. K. F., Reker‐Smit, C., Morselt, H. W. M., & Kamps, J. A. A. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.027 · Cited by 52
Brändli, A. W., Adamson, E. D., & Simons, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93011-5 · Cited by 51
Tumor-Directed Targeting of Liposomes
Park, Y. S. (2002) · Bioscience Reports · doi:10.1023/a:1020190606757 · Cited by 51
Wikswo, J. P., Prokop, A., Baudenbacher, F. J., Cliffel, D. E., Csukás, B., & Velkovsky, M. (2006) · IEE Proceedings - Nanobiotechnology · doi:10.1049/ip-nbt:20050045 · Cited by 51
Self-citationIn vivo tumor imaging in mice with near-infrared labeled endostatin
Citrin, D. E., Lee, A. K., Scott, T., Sproull, M. T., Ménard, C. M., Tofilon, P. J., & Camphausen, K. A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.481.3.4 · Cited by 51
Macromolecular Colloids of Diblock Poly(amino acids) That Bind Insulin
Constancis, A., Meyrueix, R., Bryson, N., Huille, S., Grosselin, J. M., Gulik‐Krzywicki, T., & Soula, G. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1999.6383 · Cited by 48
Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs
Harvie, P., Dutzar, B., Galbraith, T., Cudmore, S., O’Mahony, D. J., Anklesaria, P. N., & Paul, R. W. (2003) · Journal of Liposome Research · doi:10.1081/lpr-120026389 · Cited by 48
Gene transfer in tissue repair: status, challenges and future directions
Eming, S. A., Krieg, T. M., & Davidson, J. M. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.9.1373 · Cited by 46
Self-citationTheoretical Models for Drug Delivery to Solid Tumors
El-Kareh, A. W., & Secomb, T. W. (1997) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v25.i6.20 · Cited by 45
Hartig, S. M., Carlesso, G., Davidson, J. M., & Prokop, A. (2006) · Biomacromolecules · doi:10.1021/bm0604754 · Cited by 44
Self-citationApplications of biomimetic systems in drug delivery
Venkatesh, S., Byrne, M. E., Peppas, N. A., & Hilt, J. Z. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1085 · Cited by 43
Mathematical Modelling of Tumour-induced Angiogenesis: Network Growth and Structure
Chaplain, M. A. J., & Anderson, A. R. A. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-8871-3_3 · Cited by 41
Tat Peptide-Mediated Intracellular Delivery of Liposomes
Levchenko, T. S., Rammohan, R., Volodina, N., & Torchilin, V. P. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)72019-9 · Cited by 41
A Generalized Framework for Network Component Analysis
Boscolo, R., Sabatti, C., Liao, J. C., & Roychowdhury, V. (2005) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2005.47 · Cited by 41
Unveiling steady‐state multiplicity in hybridoma cultures: The cybernetic approach
Namjoshi, A. A., Hu, W., & Ramkrishna, D. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10447 · Cited by 41
Modeling mitochondrial function
Balaban, R. S. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00223.2006 · Cited by 41
Evaluating Mid-(k, n) Queries Using B + -Tree
Kwon, D., Lee, T., & Lee, S. (2005) · Lecture notes in computer science · doi:10.1007/11546924_8 · Cited by 39
Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides
Oehlke, J., Lorenz, D., Wiesner, B., & Bienert, M. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.691 · Cited by 38
Mager, D. E., Neuteboom, B., & Jusko, W. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9009-z · Cited by 38
Wüstner, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413238200 · Cited by 37
Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes
Günther, M., Wagner, E., & Ogris, M. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011053174855 · Cited by 37
Miyamoto, Y., Oda, T., & Maeda, H. (1990) · PubMed · Cited by 37
Veldman, R. J., Koning, G. A., van Hell, A. J., Zerp, S. F., Vink, S. R., Storm, G., Verheij, M., & BLITTERSWIJK, W. J. V. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087486 · Cited by 37
Magnetic resonance and fluorescence based molecular imaging technologies
Sosnovik, D. E., & Weissleder, R. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7426-8_3 · Cited by 36
Architectural and Structural Optimization of the Protective Polymer Layer for Enhanced Targeting
Chen, C.-C., & Dormidontova, E. E. (2005) · Langmuir · doi:10.1021/la047109v · Cited by 32
Prokop, A., Kozlov, E., Newman, G. W., & Newman, M. J. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.1200 · Cited by 32
Self-citationInvestigation of metabolic objectives in cultured hepatocytes
Uygun, K., Matthew, H. W. T., & Huang, Y. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21237 · Cited by 32
Chiu, S. J., Marcucci, G., & Lee, R. J. (2006) · PubMed · Cited by 31
Kwon, S., Shi, K., Houston, J. P., Wang, W., Wu, Q., Li, C., & Sevick-Muraca, E. M. (2005) · Molecular Imaging · doi:10.1162/15353500200505103 · Cited by 29
An improved method of preparing microcarriers for biolistic transfection
O’Brien, J., & Lummis, S. C. R. (2002) · Brain Research Protocols · doi:10.1016/s1385-299x(02)00175-7 · Cited by 28
Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells
Hartig, S. M., Greene, R. R., Carlesso, G., Higginbotham, J. N., Khan, W. N., Prokop, A., & Davidson, J. M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.027 · Cited by 27
Self-citationMolecular MR Imaging in Oncology
Bradbury, M. S., & Hricak, H. (2005) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2005.03.008 · Cited by 26
Nanotechnology and site-targeted drug delivery
Petrak, K. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206778667497 · Cited by 26
Cargo Takes Control of Endocytosis
Haucke, V. (2006) · Cell · doi:10.1016/j.cell.2006.09.012 · Cited by 26
Phelps, M. A., Foraker, A. B., & Swaan, P. W. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02707-7 · Cited by 25
Mathematical Modeling: Epidemiology Meets Systems Biology
Ulrich, C. M., Nijhout, H. F., & Reed, M. C. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0252 · Cited by 25
Caveolae and the caveolins in human disease
Campbell, L., Gumbleton, M., & Ritchie, K. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00145-4 · Cited by 24
Mathematical model of antibody targeting: important parameters defined using clinical data
Green, A. J., Johnson, C., Adamson, K., & Begent, R. (2001) · Physics in Medicine and Biology · doi:10.1088/0031-9155/46/6/307 · Cited by 24
Mizuguchi, H., Nakagawa, T., Morioka, Y., Imazu, S., Nakanishi, M., Kondo, T., Hayakawa, T., & Mayumi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6568 · Cited by 23
Human Gene Marker/Therapy Clinical Protocols (Complete Updated Listings)
Rosenberg, S. A., Blaese, R., Brenner, M. K., Deisseroth, A., Ledley, F., Lotze, M. T., Wilson, J., Nabel, G., Cornetta, K., Economou, J. S., et al. (1996) · Human Gene Therapy · doi:10.1089/10430340050015536 · Cited by 23
Modeling of Protein Signaling Networks in Clinical ProteomicsPreprint
Geho, D. H., Petricoin, E. F., Liotta, L. A., & Araujo, R. P. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.022 · Cited by 20
Måseide, K., & Rofstad, E. K. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00154-1 · Cited by 20
Simonson, O. E., Svahn, M. G., Törnquist, E., Lundin, K. E., & Smith, C. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774580813 · Cited by 17
The biochemical and physiological characteristics of receptors
Feener, E. P., & King, G. L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00079-3 · Cited by 17
Nanoparticulate System for Efficient Gene Transfer into Refractory Cell Targets
Carlesso, G., Kozlov, E., Prokop, A., Unutmaz, D., & Davidson, J. M. (2005) · Biomacromolecules · doi:10.1021/bm0492531 · Cited by 17
Self-citationVittorio Cristini, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.2118 · Cited by 17
Optimal tumor targeting by antibodies: Development of a mathematical model
Chappell, M. J., Thomas, G. D., Godfrey, K. R., & Bradwell, A. R. (1991) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01073870 · Cited by 11
Synthetic polymer systems in drug delivery
Alexander, C. (2001) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.6.2.345 · Cited by 11
Tanaka, K., Towata, S., Nakao, K., Mizuguchi, H., Hayakawa, T., Niwa, M., Ishii, N., & Nagayama, Y. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01915.x · Cited by 11
LIPOSOME RECOGNITION BY RESIDENT AND NEWLY RECRUITED MURINE LIVER MACROPHAGES
Moghimi, S. M. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004778 · Cited by 10
Mano, Y., Suzuki, H., Terasaki, T., Iwahashi, T., Ono, K., Naito, M., Tsuruo, T., & Sugiyama, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37000-4 · Cited by 7
Systems biology and the mathematical modelling of antibody-directed enzyme prodrug therapy (ADEPT)
Varner, J. D. (2005) · Systems Biology · doi:10.1049/ip-syb:20050047 · Cited by 6
Mathematical Modeling of Marker Influx and Efflux in Cells
Heckman, C. A. (2001) · Bulletin of Mathematical Biology · doi:10.1006/bulm.2001.0216 · Cited by 6
Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis
Holčı́k, M. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.3.241 · Cited by 6
The Development of Liposomes for Enhanced Delivery of Chemotherapeutics to Tumors
Tardi, P. G., Ickenstein, L. M., Bally, M. B., & Mayer, L. D. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-167-1_4 · Cited by 5
Sinek, J. P., Frieboes, H. B., Balakrishnan, S., Sanga, S., & Vittorio Cristini, C. (2003) · Nanotechnologies for the Life Sciences · doi:10.1002/9783527610419.ntls0036 · Cited by 4
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Vivero‐Escoto, J. L., Slowing, I. I., Trewyn, B. G., & Lin, V. S. ‐. (2010) · Small · doi:10.1002/smll.200901789 · Cited by 998
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Metadata
- Authors
- Prokop, A., & Davidson, J. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 97
- Issue
- 9
- Pages
- 3518-3590
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2102819518
- Cited by
- 363
- References
- 466
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.